PT-141 (Bremelanotide) 10mg

PT-141 (Bremelanotide) is a synthetic peptide originally derived from Melanotan II. Unlike other sexual health therapies that act on the vascular system, PT-141 works directly on the nervous system to enhance sexual desire and arousal. It has been studied in both men and women for treatment of sexual dysfunction.

• Sexual Health Support: Enhances libido and sexual arousal.

• Unique Mechanism: Targets melanocortin receptors in the brain, not the vascular system.

• Broad Applications: Studied in both male erectile dysfunction and female sexual interest/arousal disorder.

• Rapid Onset: Effects reported within hours of administration.

• FDA-approved under the name Vyleesi for treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.

• Studies show improvement in erectile function in men.

• Demonstrated efficacy in individuals unresponsive to PDE5 inhibitors (e.g., sildenafil).

• Common side effects: flushing, nausea, headache, injection site reactions.

• Some individuals may experience transient increases in blood pressure.

• Contraindicated in uncontrolled hypertension or cardiovascular disease.